Brief: Asep Medical Announces Licensing Arrangement For A Novel AI-Driven Sepsis Diagnosis Technology
02/02/2022 11:23
Feb 2 (Reuters) - Asep Medical Holdings Inc ASEP.CD :
* ASEP MEDICAL HOLDINGS INC. ANNOUNCES AN EXCLUSIVE
LICENSING
ARRANGEMENT FOR A PATENTED AND NOVEL AI-DRIVEN SEPSIS DIAGNOSIS
TECHNOLOGY DEVELOPED AT THE UNIVERSITY OF BRITISH COLUMBIA (UBC)
Source text for Eikon: ID:nCNWw32lga
Further company coverage: ASEP.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Asep Medical Holdings
See all newsBrief: Asep Medical Holdings Says Have Applied To List The Common Shares On The Nasdaq Stock Market Llc Under The Symbol “Seps”
Brief: Asep Inc. Announces The Appointment Of Jacqueline M. Tucker As CFO
Brief: Asep Medical Holdings Inc. Taking Actions For Revocation Of Cease Trade Order
Brief: Asep Medical Announces Licensing Arrangement For A Novel AI-Driven Sepsis Diagnosis Technology